CTOs on the Move

Menlo Therapeutics

www.menlotherapeutics.com

 
We are a late stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with various conditions. We believe that serlopitant, a highly selective small molecule inhibitor of the neurokinin 1 receptor, or NK1R, given as a once daily, oral tablet, has the potential to significantly alleviate pruritus associated with various conditions.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Solomon Wang
 Director of Information Technology Profile

Funding

Menlo Therapeutics raised $50M on 07/18/2017

Similar Companies

Streamfeeder

Streamfeeder is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

GTESS Corporation

GTESS Corporation is a Richardson, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Neovia Group

Neovia benefits from a multi-activities, multi-species and multi-areas experience. It is a reference in terms of innovative solutions in breeding.

Total Scope Inc

Total Scope Inc is a Upper Chichester, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bio-Ops

Bio-Ops is a Los Altos, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.